Integra LifeSciences (IART) Implants PyroTITAN in First Patient
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Join SI Premium – FREE
Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced the first implantation of the PyroTITAN Humeral Resurfacing Implant in patients in Milan, Italy and Stockholm, Sweden. The PyroTITAN implant is used in shoulder resurfacing, a more conservative alternative to shoulder replacement surgery.
Alessandro Castagna, MD at Humanitas Institute IRCCS, Milan, Italy, implanted the PyroTITAN device in a 70 year old male with glenohumeral degenerative osteoarthritis and a concentrically worn glenoid. "Because of his active lifestyle, a total shoulder replacement with a typical stemmed humeral component was not desirable; we also wanted to avoid a potential periprosthetic fracture if the patient should fall," said Dr. Castagna. "We chose the PyroTITAN® PyroCarbon humeral resurfacing as an alternative treatment. It also offered excellent wear characteristics against cartilage and bone when compared to metal alternatives, which allowed the glenoid to remain untouched."
Alessandro Castagna, MD at Humanitas Institute IRCCS, Milan, Italy, implanted the PyroTITAN device in a 70 year old male with glenohumeral degenerative osteoarthritis and a concentrically worn glenoid. "Because of his active lifestyle, a total shoulder replacement with a typical stemmed humeral component was not desirable; we also wanted to avoid a potential periprosthetic fracture if the patient should fall," said Dr. Castagna. "We chose the PyroTITAN® PyroCarbon humeral resurfacing as an alternative treatment. It also offered excellent wear characteristics against cartilage and bone when compared to metal alternatives, which allowed the glenoid to remain untouched."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Kimbell Royalty closes $221.2M mineral rights acquisition
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
